Triumvira Immunologics, Inc.
3 clinical trials · Sponsor
◉ Watch Triumvira Immunologics, Inc.
| Record | Firm | Date |
|---|---|---|
| TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3) (NCT05862324) | Triumvira Immunologics, Inc. | 2023-08-23 |
| TAC T-cells for the Treatment of HER2-positive Solid Tumors (NCT04727151) | Triumvira Immunologics, Inc. | 2021-04-19 |
| Autologous TAC T Cells Targeting CD19 in R/R Large B-Cell Lymphoma (NCT03880279) | Triumvira Immunologics, Inc. | 2020-05-01 |
Track Triumvira Immunologics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.